CS

Charu Sharma

Active Director Director DIN 06619873
DIN 06619873 First appointment Jul 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2013
Shareholding value •••• Premium profile

About Charu Sharma

Data last updated:

Charu Sharma is a Director at Hazor Pharmaceuticals Private Limited (since 2013). The company operates in Trading. Hazor Pharmaceuticals Private Limited reported revenue of ₹93,979 (FY 2025).

DIN 06619873
Primary Designation Director
Industry Trading
First Appointment 05 Jul 2013
Oldest Company Age 13 yrs
Largest company Hazor Pharmaceuticals Private Limited · ₹93,979 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jul 20132013₹93,979 (FY 2025)Active

Board colleagues of Charu Sharma

NameDINCompanyDesignation
Sohini Shankar11315886Hazor Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hazor Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Charu Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charu Sharma

Charu Sharma currently holds 1 directorship: Hazor Pharmaceuticals Private Limited (Director, since 05 Jul 2013, revenue ₹93,979 (FY 2025)).

Charu Sharma was first appointed on 05 Jul 2013 as Director at Hazor Pharmaceuticals Private Limited.

The current boards of Charu Sharma's companies include Sohini Shankar (Hazor Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available